The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure
NCT01937858 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-02-20
Summary
The value of HbA1c as a tool to determine glycemic control in patients with diabetes and renal failure has not been well studied, the same accepted normal ranges for HbA1c are applied to all patients with diabetes regardless of their renal function. We would like to evaluate the use of HbA1c as a tool of assessing long term glycemic control in this subgroup of patients with diabetes and evaluate the effect of dialysis on HbA1c
Conditions
- Diabetes
- Renal Failure
Sponsors & Collaborators
-
Reem Mohammad Alamoudi
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-07-31
More Related Trials
-
Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient
NCT03859817 ·Status: UNKNOWN
-
A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus
NCT01273558 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study
NCT02848508 ·Status: WITHDRAWN ·Phase: PHASE2
-
T-regulatory Cells in Diabetic Type Two Nephropathy
NCT03591939 ·Status: UNKNOWN
-
Lipid Profile in Diabetic and Non Diabetic CKD Patients
NCT06802978 ·Status: RECRUITING
-
Fib to Alb Ratio in Type 2 Dkd
NCT05691985 ·Status: NOT_YET_RECRUITING
-
Variation in Serum Levels of Metformin in Patients With Reduced Renal Function
NCT00767351 ·Status: COMPLETED
-
Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
NCT06668753 ·Status: NOT_YET_RECRUITING
-
A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney Function
NCT06370819 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function
NCT00501462 ·Status: COMPLETED ·Phase: PHASE1
-
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
NCT04498156 ·Status: COMPLETED
-
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
NCT06069076 ·Status: NOT_YET_RECRUITING
-
Real-world Aliskiren Use in Diabetic Patients
NCT01393860 ·Status: COMPLETED
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacity and Safety of Metformin XR in CKD Stage 1 to 3
NCT02895750 ·Status: COMPLETED ·Phase: PHASE2
-
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis
NCT06031389 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Therapeutic Drug Use for CKD Patients
NCT05818995 ·Status: UNKNOWN
-
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
NCT03795389 ·Status: COMPLETED ·Phase: PHASE1
-
Compare Serum Klotho Levels in Patients on Oral Antidiabetic Treatment
NCT03585777 ·Status: UNKNOWN
-
The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy
NCT05061459 ·Status: UNKNOWN
-
Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
NCT05469659 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
NCT00938158 ·Status: COMPLETED ·Phase: PHASE1
-
Renal Impairment in Type 2 Diabetic Subjects
NCT00554450 ·Status: COMPLETED ·Phase: PHASE1
-
Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes
NCT01069549 ·Status: COMPLETED
-
Glargine Versus NPH in Patients With Chronic Kidney Disease
NCT02451917 ·Status: COMPLETED ·Phase: PHASE4